Body Composition

SLU-PP-332

SLU-PP-332 (ERR Agonist / "Exercise Mimetic")

Exercise-mimetic research compound targeting oxidative metabolism

Research Status: Preclinical; early research compound SLU PP 332
Mechanism of Action

How it works

SLU-PP-332 is an agonist of the estrogen-related receptors (ERRalpha/beta/gamma), master regulators of mitochondrial and oxidative metabolism. Activating them is studied to mimic some metabolic adaptations of endurance exercise.

Areas of Research

What the research explores

In published research, SLU-PP-332 has been studied in connection with the following. These describe findings reported in the literature — not approved uses, claims, or outcomes to expect.

  • Activates ERR oxidative-metabolism pathways
  • Studied as an "exercise mimetic" in models
  • Investigated for endurance and fat oxidation
  • Researched for metabolic and body-composition markers
  • Novel mechanism distinct from incretins
Research Highlight

A 2023 study reported that SLU-PP-332 increased running endurance and oxidative metabolism in mice, prompting interest in ERR agonism as an exercise-mimetic strategy.

Safety Profile

Adverse events & gaps

Preclinical - human safety not established. For research use only.



Stay Informed on
Peptide Research

Research summaries, newly documented peptides, and clinical trial updates delivered to your inbox.

No spam. Unsubscribe at any time.